Samuel Bates Martin - Jun 16, 2022 Form 4 Insider Report for Celldex Therapeutics, Inc. (CLDX)

Role
SVP AND CFO
Signature
/s/ Anthony S. Marucci, attorney-in-fact for Samuel Bates Martin
Stock symbol
CLDX
Transactions as of
Jun 16, 2022
Transactions value $
$0
Form type
4
Date filed
6/17/2022, 04:13 PM
Previous filing
Dec 28, 2021
Next filing
Aug 15, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLDX Incentive Stock Option (right to buy) Award $0 +85K $0.00 85K Jun 16, 2022 Common Stock 85K $22.48 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan.
F2 25% vest on June 16, 2023 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters.